Key result
Antibiotic exposure, particularly macrolides, links to incident AF, though evidence remains limited and confounded.
Why the study?
A possible association between antibiotic exposure and AF has been reported, but infection itself is an established AF trigger and AF-specific clinical evidence remains limited and heterogeneous.
Does antibiotic exposure increase susceptibility to atrial fibrillation independent of underlying infection in patients treated for infectious diseases?
Does antibiotic exposure increase susceptibility to atrial fibrillation independent of underlying infection in patients treated for infectious diseases?
Answers are grounded in this paper and cite their sources.
Current evidence linking antibiotics to atrial fibrillation is hypothesis-generating and heavily confounded by underlying infection, though clinicians should monitor for indirect proarrhythmic pathways such as antibiotic-induced electrolyte disturbances and drug-drug interactions with anticoagulants or rate-control agents.
Antibiotic‐associated cardiotoxicity has traditionally been discussed in relation to QT prolongation and torsade de pointes. A possible association between antibiotic exposure and atrial fibrillation (AF) has also been reported, but infection itself is an established AF trigger. This review distinguishes observational epidemiology, pharmacovigilance analyses, clinical case reports, and experimental studies when considering antibiotic classes and proposed mechanisms. Pharmacovigilance findings include AF reporting associations for macrolides, whereas much of the cardiovascular evidence for fluoroquinolones concerns QT prolongation and ventricular arrhythmias. AF‐specific clinical evidence remains limited and heterogeneous. Proposed pathways include electrolyte disturbances, autonomic effects, drug interactions, inflammatory or allergic reactions, myocardial injury, mitochondrial dysfunction, oxidative stress, and gut dysbiosis. These pathways provide biological plausibility but do not demonstrate that antibiotic exposure causes clinically relevant atrial changes or AF. FAERS and VigiBase can identify potential safety signals but cannot independently establish incidence or causality. Confounding by infection type and severity, patient susceptibility, and concomitant treatments limits interpretation of clinical associations. The qualitative AF relevance categories summarize the available support for a potential association and do not quantify clinical risk or formally grade evidence certainty. Overall, the proposed associations remain hypothesis‐generating. Appropriately controlled studies are needed to distinguish potential antibiotic effects from infection‐related AF and to determine their clinical relevance.
No takes yet. Share an insight, caveat, or question.
Ono K (2026) conducted a review in Atrial fibrillation and bacterial infections. Antibiotic exposure vs. Unexposed individuals or alternative antibiotic classes was evaluated on Atrial fibrillation. Antibiotic exposure shows hypothesis-generating associations with atrial fibrillation, particularly for macrolides, but clinical evidence remains limited and heavily confounded by underlying infection.
Synapse has enriched 10 related papers. Consider them for comparative context: